Search research articles
Contact Us
Filters
Showing results (181-190 of 205) with videos related to
Page
of 21
Sort By:
The Lancet. Gastroenterology & Hepatology
|
February 12, 2020
Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial
Eric Rullier, Véronique Vendrely, Julien Asselineau, et al.
Annals of Surgical Oncology
|
April 11, 2021
Limited Resection Versus Pancreaticoduodenectomy for Duodenal Gastrointestinal Stromal Tumors? Enucleation Interferes in the Debate: A European Multicenter Retrospective Cohort Study
Clément Dubois, Frederiek Nuytens, Hélène Behal, et al.
Cancer Research
|
June 11, 2015
Correlation between Density of CD8+ T-cell Infiltrate in Microsatellite Unstable Colorectal Cancers and Frameshift Mutations: A Rationale for Personalized Immunotherapy
Pauline Maby, David Tougeron, Mohamad Hamieh, et al.
British Journal of Cancer
|
August 4, 2017
Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours
David Sefrioui, France Blanchard, Emmanuel Toure, et al.
International Journal of Cancer
|
December 23, 2016
Copy number variations in DCC/18q and ERBB2/17q are associated with disease-free survival in microsatellite stable colon cancer
David Sefrioui, Thomas Vermeulin, France Blanchard, et al.
The Lancet. Oncology
|
July 28, 2020
Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study
Diane Goéré, Olivier Glehen, François Quenet, et al.
Annals of Surgery
|
October 22, 2019
Does A Longer Waiting Period After Neoadjuvant Radio-chemotherapy Improve the Oncological Prognosis of Rectal Cancer?: Three Years' Follow-up Results of the Greccar-6 Randomized Multicenter Trial
Jérémie H Lefèvre, Laurent Mineur, Marine Cachanado, et al.
World Journal of Surgery
|
March 20, 2026
Surgical Management of Zollinger-Ellison Syndrome in Multiple Endocrine Neoplasia Type 1 an AFCE and GTE Cohort Study. (Association Francophone de Chirurgie Endocrinienne and Groupe d'étude des Tumeurs Endocrines)
Sébastien Gaujoux, François Pattou, Guillaume Cadiot, et al.
Acta Chirurgica Belgica
|
June 5, 2026
Risk factors associated with urinary tract infection within 4 days of male rectal cancer surgery in the era of enhanced recovery after surgery (ERAS) programs
Jean-Luc Faucheron, Fatah Tidadini, Zaher Lakkis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2016
Effect of Interval (7 or 11 weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR-6)
Jérémie H Lefevre, Laurent Mineur, Salma Kotti, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 205) with videos related to
Sort By:
Page
of 21
The Lancet. Gastroenterology & Hepatology
|
February 12, 2020
Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial
Eric Rullier, Véronique Vendrely, Julien Asselineau, et al.
Annals of Surgical Oncology
|
April 11, 2021
Limited Resection Versus Pancreaticoduodenectomy for Duodenal Gastrointestinal Stromal Tumors? Enucleation Interferes in the Debate: A European Multicenter Retrospective Cohort Study
Clément Dubois, Frederiek Nuytens, Hélène Behal, et al.
Cancer Research
|
June 11, 2015
Correlation between Density of CD8+ T-cell Infiltrate in Microsatellite Unstable Colorectal Cancers and Frameshift Mutations: A Rationale for Personalized Immunotherapy
Pauline Maby, David Tougeron, Mohamad Hamieh, et al.
British Journal of Cancer
|
August 4, 2017
Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours
David Sefrioui, France Blanchard, Emmanuel Toure, et al.
International Journal of Cancer
|
December 23, 2016
Copy number variations in DCC/18q and ERBB2/17q are associated with disease-free survival in microsatellite stable colon cancer
David Sefrioui, Thomas Vermeulin, France Blanchard, et al.
The Lancet. Oncology
|
July 28, 2020
Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study
Diane Goéré, Olivier Glehen, François Quenet, et al.
Annals of Surgery
|
October 22, 2019
Does A Longer Waiting Period After Neoadjuvant Radio-chemotherapy Improve the Oncological Prognosis of Rectal Cancer?: Three Years' Follow-up Results of the Greccar-6 Randomized Multicenter Trial
Jérémie H Lefèvre, Laurent Mineur, Marine Cachanado, et al.
World Journal of Surgery
|
March 20, 2026
Surgical Management of Zollinger-Ellison Syndrome in Multiple Endocrine Neoplasia Type 1 an AFCE and GTE Cohort Study. (Association Francophone de Chirurgie Endocrinienne and Groupe d'étude des Tumeurs Endocrines)
Sébastien Gaujoux, François Pattou, Guillaume Cadiot, et al.
Acta Chirurgica Belgica
|
June 5, 2026
Risk factors associated with urinary tract infection within 4 days of male rectal cancer surgery in the era of enhanced recovery after surgery (ERAS) programs
Jean-Luc Faucheron, Fatah Tidadini, Zaher Lakkis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2016
Effect of Interval (7 or 11 weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR-6)
Jérémie H Lefevre, Laurent Mineur, Salma Kotti, et al.
Page
of 21